Compare PYPD & IROQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PYPD | IROQ |
|---|---|---|
| Founded | 2008 | 1883 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 73.0M | 84.4M |
| IPO Year | 2020 | 2011 |
| Metric | PYPD | IROQ |
|---|---|---|
| Price | $4.72 | $26.60 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | ★ 74.5K | 2.7K |
| Earning Date | 02-11-2026 | 01-29-2026 |
| Dividend Yield | N/A | ★ 1.50% |
| EPS Growth | N/A | ★ 157.16 |
| EPS | N/A | ★ 1.60 |
| Revenue | N/A | ★ $27,979,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $16.58 |
| Revenue Growth | N/A | ★ 24.68 |
| 52 Week Low | $2.30 | $22.84 |
| 52 Week High | $4.97 | $27.01 |
| Indicator | PYPD | IROQ |
|---|---|---|
| Relative Strength Index (RSI) | 75.13 | 51.09 |
| Support Level | $4.10 | $26.60 |
| Resistance Level | $4.97 | $26.98 |
| Average True Range (ATR) | 0.22 | 0.21 |
| MACD | 0.06 | -0.04 |
| Stochastic Oscillator | 80.56 | 34.48 |
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
IF Bancorp Inc is a holding company mainly engaged in the business of directing, planning, and coordinating the business activities of Iroquois Federal. The company, in association, takes deposits from the general public and invests those deposits together with funds generated from operations and borrowings in various loans such as multi-family residential and mortgage loans, commercial real estate loans, home equity lines of credit, consumer loans, etc., and offers a variety of deposit accounts and alternative delivery channels. In addition to the traditional banking products and services, the group also offers a full line of property and casualty insurance products, annuities, mutual funds, individual securities, managed accounts, and other financial services.